Presence of N-2-(deoxyguanosin-8-yl)-2-amino-3,8-demethylimidazo [4,5-f]quinoxaline (dG-C8-MeIQx) in human tissues

被引:79
作者
Totsuka, Y [1 ]
Fukutome, K [1 ]
Takahashi, M [1 ]
Takahashi, S [1 ]
Tada, A [1 ]
Sugimura, T [1 ]
Wakabayashi, K [1 ]
机构
[1] NAGOYA CITY UNIV, SCH MED, DEPT PATHOL 1, MIZUHO KU, NAGOYA, AICHI 467, JAPAN
关键词
D O I
10.1093/carcin/17.5.1029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One of the mutagenic and carcinogenic heterocyclic amines (HCAs), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), is present in cooked foods and we are chronically exposed to this compound in our daily life, To study the role of HCAs in human carcinogenesis, we analyzed MeIQx-DNA adducts in 38 DNA samples obtained from surgical and autopsy specimens by the P-32-postlabeling method under adduct-intensification conditions with the modification of additional digestion with nuclease P1 and phosphodiesterase I after P-32-labeling at 5'-hydroxyl termini. This modified P-32-postlabeling method can detect N-2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline 5'-monophosphate (5'-pdG-C8-MeIQx) at levels down to 1/10(10) nucleotides, The DNA samples from colon and rectum surgical specimens and a kidney taken at autopsy were found to contain an adduct spot corresponding to that of standard 5'-pdG-C8-MeIQx on TLC at levels of 14, 18 and 1.8 per 10(10) nucleotides, respectively, Each adduct spot was extracted from TLC and identified to be 5'-pdG-C8-MeIQx by HPLC. Thus, MeIQx-DNA adducts actually exist in human tissues and this adduct formation may be involved in human cancer development.
引用
收藏
页码:1029 / 1034
页数:6
相关论文
共 43 条
[1]   CARCINOGENICITY OF 2-AMINO-3-METHYLIMIDAZO[4,5-F]QUINOLINE IN NONHUMAN-PRIMATES - INDUCTION OF TUMORS IN 3 MACAQUES [J].
ADAMSON, RH ;
THORGEIRSSON, UP ;
SNYDERWINE, EG ;
THORGEIRSSON, SS ;
REEVES, J ;
DALGARD, DW ;
TAKAYAMA, S ;
SUGIMURA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1990, 81 (01) :10-14
[2]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[3]   RELEVANCE OF METABOLIC POLYMORPHISMS TO HUMAN CARCINOGENESIS - EVALUATION OF EPIDEMIOLOGIC EVIDENCE [J].
CAPORASO, N ;
LANDI, MT ;
VINEIS, P .
PHARMACOGENETICS, 1991, 1 (01) :4-19
[4]   MEAT, COOKING METHODS AND COLORECTAL-CANCER - A CASE-REFERENT STUDY IN STOCKHOLM [J].
DEVERDIER, MG ;
HAGMAN, U ;
PETERS, RK ;
STEINECK, G ;
OVERVIK, E .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (04) :520-525
[5]   INDUCTION OF LYMPHOMA IN CDF1 MICE BY THE FOOD MUTAGEN, 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE [J].
ESUMI, H ;
OHGAKI, H ;
KOHZEN, E ;
TAKAYAMA, S ;
SUGIMURA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (12) :1176-1178
[6]   DOSE-RESPONSE STUDIES OF MEIQX IN RAT-LIVER AND LIVER DNA AT LOW-DOSES [J].
FRANTZ, CE ;
BANGERTER, C ;
FULTZ, E ;
MAYER, KM ;
VOGEL, JS ;
TURTELTAUB, KW .
CARCINOGENESIS, 1995, 16 (02) :367-373
[7]   ANALYSIS OF DNA-ADDUCTS OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE IN RAT AND HUMAN TISSUES BY ALKALINE-HYDROLYSIS AND GAS-CHROMATOGRAPHY ELECTRON-CAPTURE MASS-SPECTROMETRY - VALIDATION BY COMPARISON WITH P-32 POSTLABELING [J].
FRIESEN, MD ;
KADERLIK, K ;
LIN, DX ;
GARREN, L ;
BARTSCH, H ;
LANG, NP ;
KADLUBAR, FF .
CHEMICAL RESEARCH IN TOXICOLOGY, 1994, 7 (06) :733-739
[8]   DETECTION OF GUANINE-C8-2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE ADDUCT AS A SINGLE SPOT ON THIN-LAYER CHROMATOGRAPHY BY MODIFICATION OF THE P-32 POSTLABELING METHOD [J].
FUKUTOME, K ;
OCHIAI, M ;
WAKABAYASHI, K ;
WATANABE, S ;
SUGIMURA, T ;
NAGAO, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (02) :113-117
[9]   HUMAN CYTOCHROMES-P450 - PROBLEMS AND PROSPECTS [J].
GONZALEZ, FJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (09) :346-352
[10]   P-32 POST-LABELING ANALYSIS OF NONRADIOACTIVE AROMATIC CARCINOGEN DNA ADDUCTS [J].
GUPTA, RC ;
REDDY, MV ;
RANDERATH, K .
CARCINOGENESIS, 1982, 3 (09) :1081-1092